Annovis Bio Announces the Filing of New Patent Application for Treatment of Mental Illnesses Expanding the Company's Portfolio -January 30, 2024 at 08:02 am EST
MALVERN, Pa., Jan. 30, 2024 -- Annovis Bio, Inc. , a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, announced the filing of a patent application...
United States Maria Maccecchini Marial Maccecchini Annovis Bio Annovis Bio Inc Company Annual Report On Form
Source: marketscreener.com